Background: The "Severe Acute Respiratory Syndrome Coronavirus 2" (SARS-CoV-2) disease has resulted in a worldwide challenging and dangerous pandemic, COVID-19 vaccines have been preventing serious morbidities and mortality associated with the infection. However, in addition to these findings, some unusual adverse effects have been reported. Vaccine side effects are common. They demonstrate that immunizations are effective, and that the immune system is responding. For assessing the safety of the vaccine, side effects and adverse events are fundamental. Objective: To evaluate side effects of corona virus vaccines. Method: A prospective cohort study using a pre-organized questionnaire encompassing, demographic, general health, the status of SARS-CoV-2 infection, vaccination, associated adverse events, breakthrough infections and their IgG antispike antibody titers; in a population comprising 200 individuals aged 18 and above who received 2 doses of one of covid-19 vaccines. Results: The responses of 200 individuals were analyzed statistically. Revealing that most utilized vaccine in the population was the Pfeizer-BioNtech vaccine. Side effects were generally subtle, in all three vaccines, with no serious adeverse events. Oxford-AstraZeneca vaccine however, showed fiercer side effects compared to the other two vaccines. Several side effects were more prevalent in male gender, but there was no noteworthy correlation with other factors. Conclusion: COVID-19 vaccinations appear to be safe. Although adverse events are rare on a worldwide scale, a large proportion of the world's population will be exposed to these vaccines. for this reason, their safety and tolerance must be carefully evaluated. More research is needed, however, to investigate the vaccines' long-term efficacy and safety, as well as the effect of dose, age, and general health condition on protective efficacy.